Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 18Rectal Neoplasms 10Colorectal Neoplasms 10Colonic Neoplasms 7Kidney Neoplasms 5Stomach Neoplasms 4Neuroblastoma 4Neoplasm Metastasis 4Liver Neoplasms 4Inflammatory Breast Neoplasms 4Carcinoma, Renal Cell 4Sarcoma 3Lung Neoplasms 3Gliosarcoma 3Glioblastoma 3Central Nervous System Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Intraductal, Noninfiltrating 3Carcinoma, Hepatocellular 3Brain Neoplasms 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Liposarcoma 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2Head and Neck Neoplasms 2Glioma 2Fibrosarcoma 2Esophageal Neoplasms 2

Interventions

X-Rays 6Phantoms, Imaging 6Magnetic Resonance Spectroscopy 6Specimen Handling 5Nuclear Medicine Department, Hospital 5Biopsy 4ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Vemurafenib 2LY3023414 2Doxorubicin 2Cisplatin 2Carboplatin 2cixutumumab 1cabozantinib 1Pharmacogenomic Variants 1Oxaliplatin 1Neoadjuvant Therapy 1Irinotecan 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Hepatoblastoma × Neoadjuvant Therapy × Clear all
NCT00077389 2014-06-24

Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma

National Cancer Institute (NCI)

Phase 2 Unknown
57 enrolled
Gastrointestinal

Liver Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡